16 May, EOD - Indian

SENSEX 82330.59 (-0.24)

Nifty 50 25019.8 (-0.17)

Nifty Bank 55354.9 (0.00)

Nifty IT 37972.35 (-0.84)

Nifty Midcap 100 57060.5 (0.94)

Nifty Next 50 67078.95 (1.29)

Nifty Pharma 21633.2 (-0.08)

Nifty Smallcap 100 17560.4 (1.86)

16 May, EOD - Global

NIKKEI 225 37753.72 (0.00)

HANG SENG 23345.05 (-0.46)

S&P 5960.5 (-0.45)

LOGIN HERE

companylogoSamsrita Labs Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 539267 | NSE Symbol : | ISIN : INE579N01018 | Industry : Trading |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
26-Apr-2025 30-Apr-2025 Acquisitions Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2025 inter alia to consider and approve Increase in Authorized Capital of the company and Raising of funds through issue of equity shares convertible warrants or any such other securities on preferential basis Outcome of Board Meeting held on 30.04.2025 (As Per BSE Announcement Dated on: 30/04/2025)
21-Apr-2025 26-Apr-2025 Accounts Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/04/2025 inter alia to consider and approve the Audited financial results of the company along with audit report for the quarter and year ended on 31.03.2025 Outcome of Board meeting held on 26-04-2025 for approval of audited financials of the company for the quarter and year ended on 31-03-2025 and appointment of Internal Auditors and Secretarial Auditors of the company (As Per Bse Announcement Dated on :26.04.2025)
05-Mar-2025 08-Mar-2025 Others Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2025 inter alia to consider and approve the proposal for restructuring of the business of the Company and any other matters Outcome (As Per Bse Announcement Dated on 08.03.2025)
02-Jan-2025 06-Jan-2025 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/01/2025 inter alia to consider and approve the Un-Audited financial results of the company for the quarter ended on 31.12.2024 Outcome of Board Meeting for approval of un-audited financials of the company for the quarter ended on 31-12-2024 Approval of un-audited financial results of the company for the quarter ended on 31-12-2024 (As per BSE Announcement Dated on 06/01/2025)
02-Nov-2024 11-Nov-2024 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 inter alia to consider and approve Unaudited Results for the Quarter and Half year ended 30.09.2024 Outcome of Board meeting held on 11-11-2024 for approval of un-audited financial results for the quarter ended on 30-09-2024 (As Per BSE Announcement dated on 11.11.2024)
06-Aug-2024 12-Aug-2024 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve Unaudited financial results for the quarter ended 30.06.2024 and any other business with the permission of the Chair. Unaudited Financial Results For Quarter Ended 30th June,2024 (As Per BSE Announcement Dated on: 12/08/2024)
11-May-2024 28-May-2024 Accounts Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve AUDITED FINANCIAL RESULTS The Board Meeting to be held on 25/05/2024 has been revised to 28/05/2024 The Board Meeting to be held on 25/05/2024 has been revised to 28/05/2024 (As Per BSE Announcement Dated on 21/05/2024) Audited Results for the Quarter ended 31.03.2024 (As Per BSE Announcement Dated on 28.05.2024)
23-Jan-2024 31-Jan-2024 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2024 inter alia to consider and approve the Unaudited financial results for the quarter ended 31.12.2023. Results for the quarter ended 31.12.2023 (As Per BSE Announcement dated on 31.01.2024)
06-Nov-2023 14-Nov-2023 Quarterly Results Quarterly Results Unaudited financial results for the quarter ended 30.09.2023 Outcome of Board Meeting held on 14.11.2023 (As per BSE Announcement Dated on 14/11/2023)
29-Sep-2023 29-Sep-2023 Change in Auditors Outcome of Board Meeting held on 29.09.2023
02-Sep-2023 02-Sep-2023 AGM Outcome of Board Meeting held on 02.09.2023 Change in Management Appointment of Statutory Auditor (As Per BSE Announcement Dated on 04/09/2023)
04-Aug-2023 14-Aug-2023 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 30.06.2023 Unaudited financial results for the quarter ended 30.06.2023 Unaudited financial results for the quarter ended 30.06.2023 (As Per BSE Announcement Dated on 14.08.2023)
19-May-2023 29-May-2023 Accounts Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2023 Audited Financial Results for the quarter and year ended 31.03.2023 (As Per BSE Announcement Dated on 29.05.2023)
23-Jan-2023 31-Jan-2023 Quarterly Results Samsrita Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2023 inter alia to consider and approve Unaudited financial results for the quarter ended 31.12.2022. Approval of un-audited financial results for the quarter ended 31.12.2022. (As Per BSE Announcement Dated on 31.01.2023)
21-Oct-2022 28-Oct-2022 Quarterly Results Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve Intimation of Board meeting to be held on 28.10.2022 For the unaudited financial results for the quarter ended 30.09.2022 For the unaudited financial results for the quarter ended 30.09.2022 (As Per BSE Announcement Dated on 28.10.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +